日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors

开发INER-PP-F11N作为肽-放射性核素偶联药物对抗CCK2受体过表达肿瘤

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26146565
Chang, Ming-Cheng; Chen, Chun-Tang; Chiang, Ping-Fang; Tang, I-Chung; Peng, Cheng-Liang; Wang, Yuh-Feng; Tai, Yi-Jou; Chiang, Ying-Cheng
信号转导
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy

BTLA：癌症免疫疗法中一种新兴的免疫检查点靶点

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph18121784
Chang, Ming-Cheng; Lee, Wan-Chi; Tai, Yi-Jou; Chiang, Ying-Cheng
Checkpoint
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases

几丁质酶-3样蛋白-1 (YKL40) 在癌症和其他慢性炎症相关疾病治疗中的作用

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph17030307
Chang, Ming-Cheng; Chen, Chun-Tang; Chiang, Ping-Fang; Chiang, Ying-Cheng
肿瘤
炎症
肿瘤免疫
炎症/感染
Immunology/Inflammation
发表日期：2024
文献求助 收藏

Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review

碘-123间碘苄胍（I-123 MIBG）的临床应用：一项综合综述

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph17121563
Chang, Ming-Cheng; Peng, Cheng-Liang; Chen, Chun-Tang; Shih, Ying-Hsia; Chen, Jyun-Hong; Tai, Yi-Jou; Chiang, Ying-Cheng
发表日期：2024
文献求助 收藏

Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome

纳米靶向（188）Re-脂质体放射治疗诊断转化研究

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms22083868
Chang, Chih-Hsien; Chang, Ming-Cheng; Chang, Ya-Jen; Chen, Liang-Cheng; Lee, Te-Wei; Ting, Gann
发表日期：2021
文献求助 收藏

Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star

长链非编码RNA在前列腺癌中的病理基础和临床影响：一颗冉冉升起的新星

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-018-0852-7
Xu, Tao; Lin, Chang-Ming; Cheng, Shu-Qi; Min, Jie; Li, Li; Meng, Xiao-Ming; Huang, Cheng; Zhang, Lei; Deng, Zi-Yu; Li, Jun
肿瘤
前列腺癌
肿瘤免疫
发表日期：2018
文献求助 收藏

Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment

放射线通过调节肿瘤微环境增强抗原特异性免疫疗法的远隔抗肿瘤效应

期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2017.11.011
Chang, Ming-Cheng; Chen, Yu-Li; Lin, Han-Wei; Chiang, Ying-Cheng; Chang, Chi-Fang; Hsieh, Shu-Feng; Chen, Chi-An; Sun, Wei-Zen; Cheng, Wen-Fang
肿瘤微环境
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2018
文献求助 收藏

Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma

CHI3L1 过表达与上皮性卵巢癌的化疗耐药性和不良预后相关

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.5469
Chiang, Ying-Cheng; Lin, Han-Wei; Chang, Chi-Fang; Chang, Ming-Cheng; Fu, Chi-Feng; Chen, Tsung-Ching; Hsieh, Shu-Feng; Chen, Chi-An; Cheng, Wen-Fang
卵巢癌
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

Fusion protein vaccines targeting two tumor antigens generate synergistic anti-tumor effects

靶向两种肿瘤抗原的融合蛋白疫苗可产生协同抗肿瘤效应

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0071216
Cheng, Wen-Fang; Chang, Ming-Cheng; Sun, Wei-Zen; Jen, Yu-Wei; Liao, Chao-Wei; Chen, Yun-Yuan; Chen, Chi-An
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏

Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.

在正常人群和人乳头瘤病毒感染人群中诱导人乳头瘤病毒 16 型特异性免疫反应

期刊:Immunology
影响因子:5
doi:10.1111/j.1365-2567.2005.02126.x
Cheng Wen-Fang, Lee Chien-Nan, Su Yi-Ning, Chang Ming-Cheng, Hsiao Wen-Chun, Chen Chi-An, Hsieh Chang-Yao
肿瘤
Human
肿瘤免疫
发表日期：2005
文献求助 收藏